The number of people living beyond a cancer diagnosis:
Reached nearly 14.5 million in 2014
Expected to rise to almost
19 million by 2024.
Cancer mortality is higher among men than women (207.9 per 100,000 men and 145.4 per 100,000 women). It is highest in African American men (261.5 per 100,000) and lowest in Asian/Pacific Islander women (91.2 per 100,000). Based on 2008-2012 deaths.
The number of cancer deaths (cancer mortality) is 171.2 per 100,000 men and women per year based on 2008-2012 deaths.
The number of new cases of cancer (cancer incidence) is 454.8 per 100,000 men and women per year based on 2008-2012 cases.
Cancer is the second leading global cause of death, with 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths are due to cancer.
About CIT Aware
This multi-component program features both live and online activities for providers and their patients. By providing useful information about existing and emerging immunotherapy options, we hope to offer a beneficial learning environment for our learners with the end goal of improving care for each individual patient.
Practical, valuable, unbiased information surrounding several facets of cancer immunology, including epidemiology, pathophysiology, and a detailed review of current data on the safety, efficacy and use of immunotherapy for cancer.
The Patient Toolkit
The most important member of every healthcare team is you, the patient. It is essential that every member of the healthcare team empower you with the tools necessary to make informed decisions regarding your health care. The information provided in this “Patient toolkit” is designed to answer several of your questions and provide information on certain aspects of the ever-evolving field of immunotherapy for cancer.